A double-blind randomized placebo pilot study comparing aggrenox versus placebo in heart failure patients (ASAP-HF trial)

被引：0

作者：

Liu, P-Y ^{[1
]}

Li, Y-H ^{[2
]}

Chen, J-H ^{[2
]}

Tsai, L-M ^{[3
]}

Liao, J-K ^{[4
]}

机构：

[1] Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan

[2] Natl Cheng Kung Univ Hosp, Div Cardiol, Tainan 70428, Taiwan

[3] Natl Cheng Kung Univ, Coll Med, Dept Med, Tainan 70101, Taiwan

[4] Univ Chicago, Chicago, IL 60637 USA

来源：

EUROPEAN JOURNAL OF HEART FAILURE | 2013年 / 12卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S74 / S74

页数：1

共 50 条

[21] Double-blind randomized trial of an oral contraceptive versus placebo for dysmenorrhea in adolescents
Davis, AR
O'Connell, KJ
Gallagher, NJ
Westhoff, CL
OBSTETRICS AND GYNECOLOGY, 2004, 103 (04): : 55S - 55S
[22] Assessment of the effects of zolpidem versus zopiclone and placebo in a double-blind randomized trial
Ohayon, MM
Arbus, L
Billard, M
Coquerel, A
Guieu, JD
Kullmann, B
Laffont, F
Lemoine, P
Paty, J
Pechadre, JC
Vecchierini, MF
Vespignani, H
BIOLOGICAL PSYCHIATRY, 1998, 43 : 55S - 55S
[23] Induction of labor with mifepristone - A randomized, double-blind study versus placebo
Stenlund, PM
Ekman, G
Aedo, AR
Bygdeman, M
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1999, 78 (09) : 793 - 798
[24] The effects of qishen granules for patients with chronic heart failure: A multicenter randomized double-blind placebo-controlled trial
Du, Kangjia
Liu, Junjie
Tan, Nannan
Huang, Xinyi
Wang, Juan
Zhao, Huihui
Wang, Wei
FRONTIERS IN PHARMACOLOGY, 2022, 13
[25] Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial
Malkin, CJ
Pugh, PJ
West, JN
van Beek, EJR
Jones, TH
Channer, KS
EUROPEAN HEART JOURNAL, 2006, 27 (01) : 57 - 64
[26] Ursodeoxycholic acid in patients with chronic heart failure. A double-blind, randomized, placebo-controlled, crossover trial
Von Haehling, S.
Schefold, J. C.
Jankowska, E. A.
Springer, J.
Vazir, A.
Kalra, P. R.
Sandek, A.
Fauler, G.
Stojakovic, T.
Trauner, M.
Ponikowski, P.
Volk, H-D.
Doehner, W.
Coats, A. J. S.
Poole-Wilson, P. A.
Anker, S. D.
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2012, 8 (01) : 110 - 117
[27] ENALAPRIL IN CHRONIC HEART-FAILURE - A DOUBLE-BLIND PLACEBO CONTROLLED TRIAL
SHARPE, N
MURPHY, J
COXON, R
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1984, 3 (02) : 471 - 471
[28] IBOPAMINE VERSUS DIGOXIN IN THE TREATMENT OF MILD CONGESTIVE-HEART-FAILURE - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
KLEBER, FX
THYROFFFRIESINGER, U
CARDIOLOGY, 1990, 77 : 75 - 80
[29] COMPARISON OF THE EFFECTS OF CILAZAPRIL AND CAPTOPRIL VERSUS PLACEBO ON EXERCISE TESTING IN CHRONIC HEART-FAILURE PATIENTS - A DOUBLE-BLIND, RANDOMIZED, MULTICENTER TRIAL
DOSSEGGER, L
BERNINK
BRAUN
BURGER
CALVERT
DEIMANN
DEVOOGT
DIPERRI
FRITZ
HERBER
HUTTON
KASTORF
KENMURE
KIDNER
KLINKE
KOSTUK
LEUTENEGGER
MANYARI
MBUYAMBA
MIZGALA
MULLER
NATHAN
NEILSON
NIEMINEN
PITT
PRAGER
QUARANTE
REDDING
SOININEN
SPECCHIA
TRIMARCO
WINDSORTOPOLSKY
CARDIOLOGY, 1995, 86 : 34 - 40
[30] Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study
Bavendiek, Udo
Berliner, Dominik
Davila, Lukas Aguirre
Schwab, Johannes
Maier, Lars
Philipp, Sebastian A.
Rieth, Andreas
Westenfeld, Ralf
Piorkowski, Christopher
Weber, Kristina
Haenselmann, Anja
Oldhafer, Maximiliane
Schallhorn, Sven
von Der Leyen, Heiko
Schroeder, Christoph
Veltmann, Christian
Stoerk, Stefan
Boehm, Michael
Koch, Armin
Bauersachs, Johann
Tebbe, Ulrich
von Haehling, Stephan
Haass, Markus
Anker, Stefan
Mohacsi, Paul
Polzl, Gerhard
Trampisch, Helmut
Zimmermann, Silke
Neuhaus, Barbara
EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (05) : 676 - 684

← 1 2 3 4 5 →